z-logo
Premium
Evaluation of high‐pressure retrograde coronary venous delivery of FGF‐2 protein
Author(s) -
Fearon William F.,
Ikeno Fumiaki,
Bailey Lynn R.,
Hiatt Bonnie L.,
Herity Niall A.,
Carter Andrew J.,
Fitzgerald Peter J.,
Rezaee Mehrdad,
Yeung Alan C.,
Yock Paul G.
Publication year - 2004
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.10790
Subject(s) - medicine , ventricle , cardiology , blood flow , coronary vein , saline , fibroblast growth factor , artery , hemodynamics , blood pressure , venous blood , coronary sinus , receptor
Delivery of angiogenic factors to ischemic myocardium remains a practical challenge. We evaluated the efficiency and efficacy of delivery of fibroblast growth factor‐2 (FGF‐2) protein via high‐pressure retrograde injection into the anterior interventricular vein (AIV) in a porcine model of chronic myocardial ischemia. Labeled FGF‐2 protein was delivered to the myocardium of three pigs via the AIV and the left anterior descending (LAD) coronary artery in three others. At 1 hr, the amount of protein in the left ventricle and the LAD region was quantified. Copper stents were implanted in the LAD of 25 pigs, resulting in chronic myocardial ischemia. At 4 weeks, microsphere‐derived myocardial blood flow was assessed at rest and during pacing. In eight pigs (AIV FGF), FGF‐2 protein (6 μg/kg) was delivered via high‐pressure retrograde injection into the AIV. Six pigs (intracoronary FGF) received the same amount of FGF‐2 by intracoronary delivery. Five pigs (AIV saline) received a placebo injection into the AIV and six pigs (control) served as controls. Four weeks later, myocardial blood flow was reassessed. At 1 hr, significantly more FGF remained in the left ventricle (1.3 vs. 0.82 μg; P < 0.04) and in the LAD region (1.2 vs. 0.64 μg; P = 0.03) after AIV compared to intracoronary delivery. Four weeks after treatment, resting LAD blood flow (normalized to right ventricular flow) improved slightly in the AIV FGF and intracoronary FGF arms (1.32–1.37 for both; P = 0.11), while it decreased significantly in the AIV saline (1.32–1.23; P = 0.02) and the control arms (1.32–1.19; P = 0.0004). Pacing LAD blood flow decreased significantly in the control arm (1.30–1.23; P < 0.05), but did not change significantly in the other three arms. High‐pressure retrograde injection into the AIV may represent an efficient and effective means for delivering angiogenic factors to ischemic myocardium. Catheter Cardiovasc Interv 2004;61:422–428. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here